help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weidner, N.
Right arrow Articles by Folkman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weidner, N.
Right arrow Articles by Folkman, J.

American Journal of Pathology, Vol 143, 401-409, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

N Weidner, PR Carroll, J Flax, W Blumenfeld and J Folkman
Department of Pathology, University of California, San Francisco 94143- 0102.

Tumor growth and metastasis require angiogenesis; and microvessel density, a measure of tumor angiogenesis, correlates with metastasis in breast and lung carcinoma. To determine how microvessel density correlated with metastasis in prostate carcinoma, we counted microvessels within the initial invasive carcinomas of 74 patients (29 with metastasis, 45 without). Microvessels were highlighted by immunostaining endothelial cells for factor VIII-related antigen. Without knowledge of the patient's cancer stage, microvessels were counted in a 200 field (0.739 mm2) in the most active areas of neovascularization. The mean microvessel count in tumors from patients with metastases was 76.8 microvessels per 200 field (median, 66; standard deviation, 44.6). The counts within carcinomas from patients without metastasis were significantly lower, 39.2 (median, 36; standard deviation, 18.6) (P < 0.0001). Microvessel counts increased with increasing Gleason's score (P < 0.0001), but this increase was present predominantly in the poorly differentiated tumors. Although Gleason's score also correlated with metastasis (P = 0.01), multivariate analysis showed that Gleason's score added no additional information to that provided by microvessel count alone. Assay of microvessel density within invasive tumors may prove valuable in selecting patients for aggressive adjuvant therapies in early prostate carcinoma.


This article has been cited by other articles:


Home page
 Br. J. Radiol.Home page
Z WIN, B ARIFF, C J HARVEY, P RANGI, R ECKERSLEY, K HAWTIN, and M J K BLOMLEY
Comparative study of experienced vs non-experienced radiologists in assessing parametric CT images of the response of the prostate gland to radiotherapy
Br. J. Radiol., July 1, 2008; 81(967): 572 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. S. Svatek, J. A. Karam, C. G. Roehrborn, P. I. Karakiewicz, K. M. Slawin, and S. F. Shariat
Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
Clin. Cancer Res., June 1, 2008; 14(11): 3362 - 3366.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S.-C. Chen, D. O. Henry, P. R. Reczek, and M. K.K. Wong
Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis
Mol. Cancer Ther., May 1, 2008; 7(5): 1227 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
X. Ning, S. Sun, L. Hong, J. Liang, L. Liu, S. Han, Z. Liu, Y. Shi, Y. Li, W. Gong, et al.
Calcyclin-Binding Protein Inhibits Proliferation, Tumorigenicity, and Invasion of Gastric Cancer
Mol. Cancer Res., December 1, 2007; 5(12): 1254 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. R. Langley and I. J. Fidler
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Endocr. Rev., May 1, 2007; 28(3): 297 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. P. Taylor and D. M. Goldenberg
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts
Mol. Cancer Ther., February 1, 2007; 6(2): 524 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. Yao, Y. Pan, J. Chen, X. Sun, Y. Qiu, and Y. Ding
Endoglin (CD105) Expression in Angiogenesis of Primary Hepatocellular Carcinomas: Analysis using Tissue Microarrays and Comparisons with CD34 and VEGF
Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 39 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Loges, H. Clausen, U. Reichelt, M. Bubenheim, A. Erbersdobler, P. Schurr, E. Yekebas, G. Schuch, J. Izbicki, K. Pantel, et al.
Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis
Clin. Cancer Res., January 1, 2007; 13(1): 76 - 80.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
Y. J. Choi, J. K. Kim, N. Kim, K. W. Kim, E. K. Choi, and K.-S. Cho
Functional MR Imaging of Prostate Cancer
RadioGraphics, January 1, 2007; 27(1): 63 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. B. Wetherill, J. K. Hess-Wilson, C. E.S. Comstock, S. A. Shah, C. R. Buncher, L. Sallans, P. A. Limbach, S. Schwemberger, G. F. Babcock, and K. E. Knudsen
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
Mol. Cancer Ther., December 1, 2006; 5(12): 3181 - 3190.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Yu, J. Wong, D. B. Lovejoy, D. S. Kalinowski, and D. R. Richardson
Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond
Clin. Cancer Res., December 1, 2006; 12(23): 6876 - 6883.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Narita, J. Staub, J. Chien, K. Meyer, M. Bauer, A. Friedl, S. Ramakrishnan, and V. Shridhar
HSulf-1 Inhibits Angiogenesis and Tumorigenesis In vivo.
Cancer Res., June 15, 2006; 66(12): 6025 - 6032.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
O. Lucidarme, Y. Kono, J. Corbeil, S.-H. Choi, J.-L. Golmard, J. Varner, and R. F. Mattrey
Angiogenesis: Noninvasive Quantitative Assessment with Contrast-enhanced Functional US in Murine Model.
Radiology, June 1, 2006; 239(3): 730 - 739.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
G Perrone, D Santini, A Verzi, B Vincenzi, D Borzomati, F Vecchio, R Coppola, A Antinori, P Magistrelli, G Tonini, et al.
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables
J. Clin. Pathol., May 1, 2006; 59(5): 492 - 496.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. M. Stefansson, H. B. Salvesen, and L. A. Akslen
Vascular proliferation is important for clinical progress of endometrial cancer.
Cancer Res., March 15, 2006; 66(6): 3303 - 3309.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
D. R. Yance Jr and S. M. Sagar
Targeting angiogenesis with integrative cancer therapies.
Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29.
[Abstract] [PDF]

Home page
 Br. J. Radiol.Home page
J F Hainfeld, D N Slatkin, T M Focella, and H M Smilowitz
Gold nanoparticles: a new X-ray contrast agent.
Br. J. Radiol., March 1, 2006; 79(939): 248 - 253.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Faderl, K.-A. Do, M. M. Johnson, M. Keating, S. O'Brien, I. Jilani, A. Ferrajoli, F. Ravandi-Kashani, C. Aguilar, A. Dey, et al.
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia
Blood, December 15, 2005; 106(13): 4303 - 4307.
[Abstract] [Full Text] [PDF]

Home page
 Indoor and Built EnvironmentHome page
V. D. Yumuk and P. F. Yumuk
What Links Obesity to Cancer?
Indoor and Built Environment, December 1, 2005; 14(6): 527 - 532.
[Abstract] [PDF]

Home page
 The OncologistHome page
W. Berry and M. Eisenberger
Achieving Treatment Goals for Hormone-Refractory Prostate Cancer with Chemotherapy
Oncologist, October 1, 2005; 10(suppl_3): 30 - 39.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Yabu, H. Tomimoto, Y. Taguchi, S. Yamaoka, Y. Igarashi, and T. Okazaki
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate
Blood, July 1, 2005; 106(1): 125 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Li, P. W. Kantoff, J. Ma, M. J. Stampfer, and D. J. George
Prediagnostic Plasma Vascular Endothelial Growth Factor Levels and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1557 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
N. Kabakci, E. Igci, M. Secil, K. Yorukoglu, U. Mungan, I. Celebi, and Z. Kirkali
Echo Contrast-Enhanced Power Doppler Ultrasonography for Assessment of Angiogenesis in Renal Cell Carcinoma
J. Ultrasound Med., June 1, 2005; 24(6): 747 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Nakanishi, S. Hiroi, S. Tominaga, S. Aida, H. Kasamatsu, S. Matsuyama, T. Matsuyama, and T. Kawai
Expression of Hypoxia-Inducible Factor-1{alpha} Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract
Clin. Cancer Res., April 1, 2005; 11(7): 2583 - 2590.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Dalal, A. M. Berry, C. J. Cullinane, D. C. Mangham, R. Grimer, I. J. Lewis, C. Johnston, V. Laurence, and S. A. Burchill
Vascular Endothelial Growth Factor: A Therapeutic Target for Tumors of the Ewing's Sarcoma Family
Clin. Cancer Res., March 15, 2005; 11(6): 2364 - 2378.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Haugen, B. Magnusson, M. Svensson, and C. Mercke
Preradiotherapy Hemoglobin Level but not Microvessel Density Predicts Locoregional Control and Survival in Laryngeal Cancer Treated with Primary Radical Radiotherapy
Clin. Cancer Res., December 1, 2004; 10(23): 7941 - 7949.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. L. Buckley, C. Roberts, G. J. M. Parker, J. P. Logue, and C. E. Hutchinson
Prostate Cancer: Evaluation of Vascular Characteristics with Dynamic Contrast-enhanced T1-weighted MR Imaging--Initial Experience
Radiology, December 1, 2004; 233(3): 709 - 715.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Chintagumpala, S. M. Blaney, L. R. Bomgaars, A. Aleksic, J. F. Kuttesch, R. A. Klenke, and S. L. Berg
Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer
J. Clin. Oncol., November 1, 2004; 22(21): 4394 - 4400.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Halin, P. Wikstrom, S. H. Rudolfsson, P. Stattin, J. A. Doll, S. E. Crawford, and A. Bergh
Decreased Pigment Epithelium-Derived Factor Is Associated with Metastatic Phenotype in Human and Rat Prostate Tumors
Cancer Res., August 15, 2004; 64(16): 5664 - 5671.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. L. Dahut, J. L. Gulley, P. M. Arlen, Y. Liu, K. M. Fedenko, S. M. Steinberg, J. J. Wright, H. Parnes, C. C. Chen, E. Jones, et al.
Randomized Phase II Trial of Docetaxel Plus Thalidomide in Androgen-Independent Prostate Cancer
J. Clin. Oncol., July 1, 2004; 22(13): 2532 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. F. Shariat, V. A. Anwuri, D. J. Lamb, N. V. Shah, T. M. Wheeler, and K. M. Slawin
Association of Preoperative Plasma Levels of Vascular Endothelial Growth Factor and Soluble Vascular Cell Adhesion Molecule-1 With Lymph Node Status and Biochemical Progression After Radical Prostatectomy
J. Clin. Oncol., May 1, 2004; 22(9): 1655 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. R. Gray, W. J. Huss, J. M. Yau, L. E. Durham, E. S. Werdin, W. K. Funkhouser Jr., and G. J. Smith
Short-Term Human Prostate Primary Xenografts: An in Vivo Model of Human Prostate Cancer Vasculature and Angiogenesis
Cancer Res., March 1, 2004; 64(5): 1712 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. L. Amling, R. H. Riffenburgh, L. Sun, J. W. Moul, R. S. Lance, L. Kusuda, W. J. Sexton, D. W. Soderdahl, T. F. Donahue, J. P. Foley, et al.
Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy
J. Clin. Oncol., February 1, 2004; 22(3): 439 - 445.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles
Body Size and Composition and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1417 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. E. Chomas, R. E. Pollard, A. R. Sadlowski, S. M. Griffey, E. R. Wisner, and K. W. Ferrara
Contrast-enhanced US of Microcirculation of Superficially Implanted Tumors in Rats
Radiology, November 1, 2003; 229(2): 439 - 446.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. De, J. Chen, N. V. Narizhneva, W. Heston, J. Brainard, E. H. Sage, and T. V. Byzova
Molecular Pathway for Cancer Metastasis to Bone
J. Biol. Chem., October 3, 2003; 278(40): 39044 - 39050.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
E F. Marback, V E A Arias, A Paranhos Jr, F A Soares, A L Murphree, and C M Erwenne
Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma
Br. J. Ophthalmol., October 1, 2003; 87(10): 1224 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
V. Nayha, J. Laitakari, and F. Stenback
Stage-Dependent Expression of an Angiogenic Agent and Vascular Organization in Experimental Skin Tumor Development
Toxicol Pathol, August 1, 2003; 31(5): 539 - 548.
[Abstract] [PDF]

Home page
 CirculationHome page
D. B. Ellegala, H. Leong-Poi, J. E. Carpenter, A. L. Klibanov, S. Kaul, M. E. Shaffrey, J. Sklenar, and J. R. Lindner
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to {alpha}v{beta}3
Circulation, July 22, 2003; 108(3): 336 - 341.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
J. K. Robinson and M. Dahiya
Basal Cell Carcinoma With Pulmonary and Lymph Node Metastasis Causing Death
Arch Dermatol, May 1, 2003; 139(5): 643 - 648.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
J. Sato, N. Segami, Y. Yoshitake, and K. Nishikawa
Correlations of the Expression of Fibroblast Growth Factor-2, Vascular Endothelial Growth Factor, and their Receptors with Angiogenesis in Synovial Tissues from Patients with Internal Derangement of the Temporomandibular Joint
J. Dent. Res., April 1, 2003; 82(4): 272 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. C. Lockhart, R. D. Braun, D. Yu, J. R. Ross, M. W. Dewhirst, J. S. Humphrey, S. Thompson, K. M. Williams, B. Klitzman, F. Yuan, et al.
Reduction of Wound Angiogenesis in Patients Treated with BMS-275291, a Broad Spectrum Matrix Metalloproteinase Inhibitor
Clin. Cancer Res., February 1, 2003; 9(2): 586 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Kim, W. Luo, D.-T. Chen, K. Earley, J. Tunstead, L.-Y. Yu-Lee, and S.-H. Lin
Antitumor Activity of the 16-kDa Prolactin Fragment in Prostate Cancer
Cancer Res., January 15, 2003; 63(2): 386 - 393.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. M. Hastings, D. R. Licence, G. J. Burton, D. S. Charnock-Jones, and S. K. Smith
Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17{beta}-Estradiol in the Mouse Uterus
Endocrinology, January 1, 2003; 144(1): 326 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Tripodis and P. Demant
Genetic Analysis of Three-dimensional Shape of Mouse Lung Tumors Reveals Eight Lung Tumor Shape-Determining (Ltsd) Loci That Are Associated with Tumor Heterogeneity and Symmetry
Cancer Res., January 1, 2003; 63(1): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. H. Liu, A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, J. F. Holland, and A. C. Levine
Prostaglandin E2 Induces Hypoxia-inducible Factor-1alpha Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line
J. Biol. Chem., December 13, 2002; 277(51): 50081 - 50086.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
E S Bamberger and C W Perrett
Angiogenesis in epithelian ovarian cancer
Mol. Pathol., December 1, 2002; 55(6): 348 - 359.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Straume, P. O. Chappuis, H. B. Salvesen, O. J. Halvorsen, S. A. Haukaas, J. R. Goffin, L. R. Begin, W. D. Foulkes, and L. A. Akslen
Prognostic Importance of Glomeruloid Microvascular Proliferation Indicates an Aggressive Angiogenic Phenotype in Human Cancers
Cancer Res., December 1, 2002; 62(23): 6808 - 6811.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. Liao, T. W.-M. Boileau, J. W. Erdman Jr, and S. K. Clinton
Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats
Carcinogenesis, October 1, 2002; 23(10): 1701 - 1712.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. D. Fox, B. Higgins, K. M. Maiese, M. Drobnjak, C. Cordon-Cardo, H. I. Scher, and D. B. Agus
Antibody to Vascular Endothelial Growth Factor Slows Growth of an Androgen-independent Xenograft Model of Prostate Cancer
Clin. Cancer Res., October 1, 2002; 8(10): 3226 - 3231.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. J. Halpern, F. Frauscher, S. E. Strup, L. N. Nazarian, P. O'Kane, and L. G. Gomella
Prostate: High-Frequency Doppler US Imaging for Cancer Detection
Radiology, October 1, 2002; 225(1): 71 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Stopeck, M. Sheldon, M. Vahedian, G. Cropp, R. Gosalia, and A. Hannah
Results of a Phase I Dose-escalating Study of the Antiangiogenic Agent, SU5416, in Patients with Advanced Malignancies
Clin. Cancer Res., September 1, 2002; 8(9): 2798 - 2805.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Cassinelli, C. Lanzi, R. Supino, G. Pratesi, V. Zuco, D. Laccabue, G. Cuccuru, E. Bombardelli, and F. Zunino
Cellular Bases of the Antitumor Activity of the Novel Taxane IDN 5109 (BAY59-8862) on Hormone-refractory Prostate Cancer
Clin. Cancer Res., August 1, 2002; 8(8): 2647 - 2654.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Sweeney, T. Karashima, S.-J. Kim, D. Kedar, B. Mian, S. Huang, C. Baker, Z. Fan, D. J. Hicklin, C. A. Pettaway, et al.
Anti-Vascular Endothelial Growth Factor Receptor 2 Antibody Reduces Tumorigenicity and Metastasis in Orthotopic Prostate Cancer Xenografts via Induction of Endothelial Cell Apoptosis and Reduction of Endothelial Cell Matrix Metalloproteinase Type 9 Production
Clin. Cancer Res., August 1, 2002; 8(8): 2714 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Hehlgans, B. Stoelcker, P. Stopfer, P. Muller, G. Cernaianu, M. Guba, M. Steinbauer, S. A. Nedospasov, K. Pfeffer, and D. N. Mannel
Lymphotoxin-{beta} Receptor Immune Interaction Promotes Tumor Growth by Inducing Angiogenesis
Cancer Res., July 15, 2002; 62(14): 4034 - 4040.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Hlatky, P. Hahnfeldt, and J. Folkman
Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us
J Natl Cancer Inst, June 19, 2002; 94(12): 883 - 893.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Agarwal, S. Strickland, I. A. McNeish, D. C. Patel, M. Foskett, J. E. Boultbee, E. S. Newlands, and M. J. Seckl
Doppler Ultrasonography of the Uterine Artery and the Response to Chemotherapy in Patients with Gestational Trophoblastic Tumors
Clin. Cancer Res., May 1, 2002; 8(5): 1142 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C.S. Brock and S.M. Lee
Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer
Eur. Respir. J., March 1, 2002; 19(3): 557 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression
Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Yuan, C.-J. Yu, K.-T. Luh, S.-H. Kuo, Y.-C. Lee, and P.-C. Yang
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer
J. Clin. Oncol., February 15, 2002; 20(4): 900 - 910.
[Abstract] [Full Text] [PDF]